The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...
Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...
That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
Rachel McGlynn wanted the choice to have kids to be hers — not dictated by the treatment for her condition. A decade into her ...
Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells ...
Add Yahoo as a preferred source to see more of our stories on Google. For many women living with lupus, the hardest part of the disease isn’t learning the diagnosis, it’s learning how much suffering ...
A common gut bacterium may be implicated in lupus kidney disease, and could potentially alter the diagnosis and treatment of ...
Finally there's a bit of good news in the long search for a viable treatment. Lupus is an autoimmune disease in which the body's immune system attacks healthy, normal tissue. It mainly strikes women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results